Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

PLD is an effective and safer alternative for treating breast cancer.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Radiofrequency exposure can stimulate hair growth by increasing IGF-1 in hair follicle cells.

Hair loss in elderly women is often caused by various factors, including hormonal changes after menopause.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Ozone therapy might improve cancer treatment and reduce its side effects.

FGF9 controls which receptors it binds to through a process where two FGF9 molecules join, and changes in FGF9 can lead to incorrect receptor activation.